These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 20523006)
41. N-glucuronidation of nicotine and cotinine in human: formation of cotinine glucuronide in liver microsomes and lack of catalysis by 10 examined UDP-glucuronosyltransferases. Ghosheh O; Hawes EM Drug Metab Dispos; 2002 Sep; 30(9):991-6. PubMed ID: 12167564 [TBL] [Abstract][Full Text] [Related]
42. The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver. Girard H; Villeneuve L; Court MH; Fortier LC; Caron P; Hao Q; von Moltke LL; Greenblatt DJ; Guillemette C Drug Metab Dispos; 2006 Jul; 34(7):1220-8. PubMed ID: 16595709 [TBL] [Abstract][Full Text] [Related]
43. Regioselective and stereospecific glucuronidation of trans- and cis-resveratrol in human. Aumont V; Krisa S; Battaglia E; Netter P; Richard T; Mérillon JM; Magdalou J; Sabolovic N Arch Biochem Biophys; 2001 Sep; 393(2):281-9. PubMed ID: 11556815 [TBL] [Abstract][Full Text] [Related]
44. How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10? Itäaho K; Laakkonen L; Finel M Drug Metab Dispos; 2010 Apr; 38(4):687-96. PubMed ID: 20089735 [TBL] [Abstract][Full Text] [Related]
45. Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1. Watanabe Y; Nakajima M; Ohashi N; Kume T; Yokoi T Drug Metab Dispos; 2003 May; 31(5):589-95. PubMed ID: 12695347 [TBL] [Abstract][Full Text] [Related]
46. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7. Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935 [TBL] [Abstract][Full Text] [Related]
47. Biosynthesis of imipramine glucuronide and characterization of imipramine glucuronidation catalyzed by recombinant UGT1A4. Qian MR; Zeng S Acta Pharmacol Sin; 2006 May; 27(5):623-8. PubMed ID: 16626519 [TBL] [Abstract][Full Text] [Related]
48. Stereoselective Glucuronidation of Bupropion Metabolites In Vitro and In Vivo. Gufford BT; Lu JB; Metzger IF; Jones DR; Desta Z Drug Metab Dispos; 2016 Apr; 44(4):544-53. PubMed ID: 26802129 [TBL] [Abstract][Full Text] [Related]
49. Complete Reaction Phenotyping of Propranolol and 4-Hydroxypropranolol with the 19 Enzymes of the Human UGT1 and UGT2 Families. Yang F; Liu S; Wolber G; Bureik M; Parr MK Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806479 [TBL] [Abstract][Full Text] [Related]
50. Evidence for differences in regioselective and stereoselective glucuronidation of silybin diastereomers from milk thistle (Silybum marianum) by human UDP-glucuronosyltransferases. Jančová P; Siller M; Anzenbacherová E; Křen V; Anzenbacher P; Simánek V Xenobiotica; 2011 Sep; 41(9):743-51. PubMed ID: 21524189 [TBL] [Abstract][Full Text] [Related]
51. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation. Miners JO; Bowalgaha K; Elliot DJ; Baranczewski P; Knights KM Drug Metab Dispos; 2011 Apr; 39(4):644-52. PubMed ID: 21245288 [TBL] [Abstract][Full Text] [Related]
52. Stereoselective glucuronidation of carvedilol by Chinese liver microsomes. You LY; Yu CN; Xie SG; Chen SQ; Zeng S J Zhejiang Univ Sci B; 2007 Oct; 8(10):756-64. PubMed ID: 17910120 [TBL] [Abstract][Full Text] [Related]
53. In vitro assessment of various cytochromes P450 and glucuronosyltransferases using the antiarrhythmic propafenone as a probe drug. Kroemer HK; Botsch S; Heinkele G; Schick M Methods Enzymol; 1996; 272():99-105. PubMed ID: 8791766 [No Abstract] [Full Text] [Related]
54. Metabolism and pharmacokinetics of morinidazole in humans: identification of diastereoisomeric morpholine N+-glucuronides catalyzed by UDP glucuronosyltransferase 1A9. Gao R; Li L; Xie C; Diao X; Zhong D; Chen X Drug Metab Dispos; 2012 Mar; 40(3):556-67. PubMed ID: 22184458 [TBL] [Abstract][Full Text] [Related]
55. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine. Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623 [TBL] [Abstract][Full Text] [Related]
56. Structure-metabolism relationships for the glucuronidation of flavonoids by UGT1A3 and UGT1A9. Xie S; Chen Y; Chen S; Zeng S J Pharm Pharmacol; 2011 Feb; 63(2):297-304. PubMed ID: 21235595 [TBL] [Abstract][Full Text] [Related]
57. Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys: contribution of UGT1A1, UGT1A8 and UGT1A9. Kishi N; Takasuka A; Kokawa Y; Isobe T; Taguchi M; Shigeyama M; Murata M; Suno M; Hanioka N Xenobiotica; 2016; 46(4):289-95. PubMed ID: 26247833 [TBL] [Abstract][Full Text] [Related]
58. Enantioselective determination of diprafenone in human plasma. Zhong D; Chen R; Fieger-Büschges H; Blume H Pharmazie; 1997 Feb; 52(2):106-9. PubMed ID: 9122271 [TBL] [Abstract][Full Text] [Related]
59. Quaternary ammonium-linked glucuronidation of tamoxifen by human liver microsomes and UDP-glucuronosyltransferase 1A4. Kaku T; Ogura K; Nishiyama T; Ohnuma T; Muro K; Hiratsuka A Biochem Pharmacol; 2004 Jun; 67(11):2093-102. PubMed ID: 15135306 [TBL] [Abstract][Full Text] [Related]
60. Glucuronidation of mono(2-ethylhexyl) phthalate in humans: roles of hepatic and intestinal UDP-glucuronosyltransferases. Hanioka N; Kinashi Y; Tanaka-Kagawa T; Isobe T; Jinno H Arch Toxicol; 2017 Feb; 91(2):689-698. PubMed ID: 27071666 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]